Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin

C. Mel Wilcox; Jeroan Allison; Keith Benzuly; Marie Borum; Byron Cryer; Tilo Grosser; Richard Hunt; Uri Ladabaum; Angel Lanas; Harold Paulus; Carol Regueiro; Robert S. Sandler; Lee Simon

doi:10.1016/j.cgh.2006.04.010

Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin

C. Mel Wilcox, Jeroan Allison, Keith Benzuly, Marie Borum, Byron Cryer, Tilo Grosser, Richard Hunt, Uri Ladabaum, Angel Lanas, Harold Paulus, Carol Regueiro, Robert S. Sandler, Lee Simon

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Original language	English (US)
Pages (from-to)	1082-1089.e4
Journal	Clinical Gastroenterology and Hepatology
Volume	4
Issue number	9
DOIs	https://doi.org/10.1016/j.cgh.2006.04.010
State	Published - Sep 2006

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.1016/j.cgh.2006.04.010

Cite this

Wilcox, C. M., Allison, J., Benzuly, K., Borum, M., Cryer, B., Grosser, T., Hunt, R., Ladabaum, U., Lanas, A., Paulus, H., Regueiro, C., Sandler, R. S., & Simon, L. (2006). Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin. Clinical Gastroenterology and Hepatology, 4(9), 1082-1089.e4. https://doi.org/10.1016/j.cgh.2006.04.010

Wilcox, CM, Allison, J, Benzuly, K, Borum, M, Cryer, B, Grosser, T, Hunt, R, Ladabaum, U, Lanas, A, Paulus, H, Regueiro, C, Sandler, RS & Simon, L 2006, 'Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin', Clinical Gastroenterology and Hepatology, vol. 4, no. 9, pp. 1082-1089.e4. https://doi.org/10.1016/j.cgh.2006.04.010

@article{f2f12f5beb3545a392586290455ea1c3,

title = "Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin",

author = "Wilcox, {C. Mel} and Jeroan Allison and Keith Benzuly and Marie Borum and Byron Cryer and Tilo Grosser and Richard Hunt and Uri Ladabaum and Angel Lanas and Harold Paulus and Carol Regueiro and Sandler, {Robert S.} and Lee Simon",

note = "Funding Information: Byron Cryer has served as a Consultant to AstraZeneca, TAP Pharmaceuticals, and Pfizer, Inc. Richard Hunt discloses having been a Consultant at some time to Merck, Pfizer, Novartis, AstraZeneca, TAP, Santarus, and Altana, and a past investigator for Merck, Novartis, AstraZeneca, TAP, and Altana. Angel Lanas has received grants and travel support from AstraZeneca, Takeda, and Pfizer, and he is a Board Member of the APPROVE Trial by Merck & Company. Harold Paulus has had no financial conflicts of interest in the past 3 years, although he has prior consultancies with many pharmaceutical companies. Robert S. Sandler is a Consultant to Merck, Bayer, Takeda, and GlaxoSmithKline, and has received grant support from Merck. Lee Simon has received speaking honoraria from Academy of Healthcare, Pfizer, Avanir, and the Foundation for Better Healthcare, and he has been a Consultant to AstraZeneca, Cerimon, Alpha Rx, Proprius, Avanir, Novartis, Pfizer, Aldolor, Paraexel, Affinergy, Aai pharma, Alder, Cell Therapeutics, Altea, Chelsea Pharmaceuticals, Cure, Coley, Puretech Ventures, Solace Pharmaceuticals, Nuvo, Dr Reddy{\textquoteright}s, Genelabs, Jazz, Medimmune, Neopharm, Neuromed, Nitec, Nomura Ventures, Purdue, Sepracor, Serono, Savient, Polymerix, Rigel, Roche, TAP, and Zydus. ",

year = "2006",

month = sep,

doi = "10.1016/j.cgh.2006.04.010",

language = "English (US)",

volume = "4",

pages = "1082--1089.e4",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B. Saunders Ltd",

number = "9",

}

TY - JOUR

T1 - Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin

AU - Wilcox, C. Mel

AU - Allison, Jeroan

AU - Benzuly, Keith

AU - Borum, Marie

AU - Cryer, Byron

AU - Grosser, Tilo

AU - Hunt, Richard

AU - Ladabaum, Uri

AU - Lanas, Angel

AU - Paulus, Harold

AU - Regueiro, Carol

AU - Sandler, Robert S.

AU - Simon, Lee

N1 - Funding Information: Byron Cryer has served as a Consultant to AstraZeneca, TAP Pharmaceuticals, and Pfizer, Inc. Richard Hunt discloses having been a Consultant at some time to Merck, Pfizer, Novartis, AstraZeneca, TAP, Santarus, and Altana, and a past investigator for Merck, Novartis, AstraZeneca, TAP, and Altana. Angel Lanas has received grants and travel support from AstraZeneca, Takeda, and Pfizer, and he is a Board Member of the APPROVE Trial by Merck & Company. Harold Paulus has had no financial conflicts of interest in the past 3 years, although he has prior consultancies with many pharmaceutical companies. Robert S. Sandler is a Consultant to Merck, Bayer, Takeda, and GlaxoSmithKline, and has received grant support from Merck. Lee Simon has received speaking honoraria from Academy of Healthcare, Pfizer, Avanir, and the Foundation for Better Healthcare, and he has been a Consultant to AstraZeneca, Cerimon, Alpha Rx, Proprius, Avanir, Novartis, Pfizer, Aldolor, Paraexel, Affinergy, Aai pharma, Alder, Cell Therapeutics, Altea, Chelsea Pharmaceuticals, Cure, Coley, Puretech Ventures, Solace Pharmaceuticals, Nuvo, Dr Reddy’s, Genelabs, Jazz, Medimmune, Neopharm, Neuromed, Nitec, Nomura Ventures, Purdue, Sepracor, Serono, Savient, Polymerix, Rigel, Roche, TAP, and Zydus.

PY - 2006/9

Y1 - 2006/9

UR - http://www.scopus.com/inward/record.url?scp=33748165573&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748165573&partnerID=8YFLogxK

U2 - 10.1016/j.cgh.2006.04.010

DO - 10.1016/j.cgh.2006.04.010

M3 - Article

C2 - 16877048

AN - SCOPUS:33748165573

SN - 1542-3565

VL - 4

SP - 1082-1089.e4

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

IS - 9

ER -

Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this